Coherus Oncology, Inc. - Common Stock (NQ:CHRS)

1.640 +0.090 (+5.81%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2026 Add to My Watchlist

Price and Volume

Volume	843,112
Open	1.560
Bid (Size)	1.510 (62,500)
Ask (Size)	1.650 (15,300)
Prev. Close	1.550
Today's Range	1.550 - 1.640
52wk Range	0.7100 - 1.890
Shares Outstanding	116,236,018
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff

January 12, 2026

Issued on behalf of Oncolytics Biotech Inc.

From Equity Insider

Via GlobeNewswire

Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 06, 2026

From Coherus Oncology, Inc.

Via GlobeNewswire

Performance

YTD	+19.7%	+19.7%
1 Month	+17.1%	+17.1%
3 Month	-2.4%	-2.4%
6 Month	+67.6%	+67.6%
1 Year	+24.2%	+24.2%

More News

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Coherus BioSciences's Earnings Outlook ↗

November 05, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Insights Ahead: Coherus BioSciences's Quarterly Earnings ↗

August 06, 2025

Via Benzinga

Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)

January 05, 2026

From Coherus Oncology, Inc.

Via GlobeNewswire

Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma

December 08, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody

November 07, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update

November 06, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer

November 06, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025

October 30, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

Coherus Oncology to Participate in Upcoming Investor Conferences

October 23, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals ↗

October 10, 2025

Via Benzinga

Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

October 03, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

September 04, 2025

Via Benzinga

Coherus Oncology to Participate in Upcoming Investor Conferences

September 03, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

Coherus (CHRS) Q2 Revenue Jumps 10% ↗

August 07, 2025

Via The Motley Fool

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

August 07, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025

July 31, 2025

From Coherus Oncology, Inc.

Via GlobeNewswire

Which stocks are moving after the closing bell on Friday? ↗

July 04, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 03, 2025

Via Benzinga

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)

May 27, 2025

From Coherus BioSciences, Inc.

Via GlobeNewswire

Top movers in Friday's after hours session ↗

May 23, 2025

Via Chartmill

Which stocks are moving before the opening bell on Tuesday? ↗

May 13, 2025

Via Chartmill

Frequently Asked Questions

Is Coherus Oncology, Inc. - Common Stock publicly traded?

Yes, Coherus Oncology, Inc. - Common Stock is publicly traded.

What exchange does Coherus Oncology, Inc. - Common Stock trade on?

Coherus Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Coherus Oncology, Inc. - Common Stock?

The ticker symbol for Coherus Oncology, Inc. - Common Stock is CHRS on the Nasdaq Stock Market

What is the current price of Coherus Oncology, Inc. - Common Stock?

The current price of Coherus Oncology, Inc. - Common Stock is 1.640

When was Coherus Oncology, Inc. - Common Stock last traded?

The last trade of Coherus Oncology, Inc. - Common Stock was at 01/21/26 04:00 PM ET

What is the market capitalization of Coherus Oncology, Inc. - Common Stock?

The market capitalization of Coherus Oncology, Inc. - Common Stock is 190.63M

How many shares of Coherus Oncology, Inc. - Common Stock are outstanding?

Coherus Oncology, Inc. - Common Stock has 191M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.